A shorter MPFI designed specifically for patients with chronic pain proved generally valid and reliable on a group level, according to a recent study.
Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...
AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...
The following is a summary of “Development and Validation of a Short Version (PAIC6) of the Pain Assessment in Impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback